Federated Hermes
CGEM icon

Federated Hermes’s Cullinan Oncology CGEM Stock Holding History

Federated Hermes’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.33K Buy
+516
New +$6.63K ﹤0.01% 1860
2025
Q3 		– Sell
-1,495
Closed -$11.3K – 2134
2025
Q2 		$11.3K Sell
1,495
-963
-39% -$7.74K ﹤0.01% 1804
2025
Q1 		$18.6K Sell
2,458
-1,344
-35% -$12.9K ﹤0.01% 1733
2024
Q4 		$46.3K Buy
3,802
+1,525
+67% +$21.9K ﹤0.01% 1684
2024
Q3 		$38.1K Buy
2,277
+2,116
+1,314% +$37.5K ﹤0.01% 1694
2024
Q2 		$2.81K Sell
161
-83
-34% -$1.77K ﹤0.01% 1883
2024
Q1 		$4.16K Buy
+244
New +$3.77K ﹤0.01% 1860
2023
Q4 		– Sell
-20,000
Closed -$181K – 2063
2023
Q3 		$181K Buy
+20,000
New +$208K ﹤0.01% 1538

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return